Found: 14
Select item for more details and to access through your institution.
Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 10, p. 1665, doi. 10.3390/ijms17101665
- By:
- Publication type:
- Article
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 3, p. 679, doi. 10.1007/s10549-020-05662-x
- By:
- Publication type:
- Article
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 733, doi. 10.1007/s10549-017-4372-8
- By:
- Publication type:
- Article
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 161, n. 1, p. 83, doi. 10.1007/s10549-016-4026-2
- By:
- Publication type:
- Article
Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 154, n. 3, p. 563, doi. 10.1007/s10549-015-3636-4
- By:
- Publication type:
- Article
The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.
- Published in:
- Breast Cancer Research & Treatment, 2015, v. 153, n. 2, p. 407, doi. 10.1007/s10549-015-3532-y
- By:
- Publication type:
- Article
Inflammatory breast cancer (IBC): clues for targeted therapies.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 140, n. 1, p. 23, doi. 10.1007/s10549-013-2600-4
- By:
- Publication type:
- Article
AZD8931, an equipotent, reversible inhibitor of signaling by Epidermal Growth Factor Receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/1756-9966-33-47
- By:
- Publication type:
- Article
EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-70
- By:
- Publication type:
- Article
Antisense MDM2 enhances the response of androgen insensitive human prostate cancer cells to androgen deprivation in vitro and in vivo.
- Published in:
- Prostate, 2008, v. 68, n. 6, p. 599, doi. 10.1002/pros.20731
- By:
- Publication type:
- Article
Antisense Bcl‐2 sensitizes prostate cancer cells to radiation.
- Published in:
- Prostate, 2005, v. 65, n. 4, p. 331, doi. 10.1002/pros.20303
- By:
- Publication type:
- Article
Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivationThe contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the US Department of Defense.
- Published in:
- Prostate, 2004, v. 60, n. 3, p. 187, doi. 10.1002/pros.20044
- By:
- Publication type:
- Article
PKA knockdown enhances cell killing in response to radiation and androgen deprivation.
- Published in:
- International Journal of Cancer, 2011, v. 128, n. 4, p. 962, doi. 10.1002/ijc.25634
- By:
- Publication type:
- Article
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1296, doi. 10.1634/theoncologist.2016-0297
- By:
- Publication type:
- Article